Biotechs Bounce With Good NASDAQ Tape: Ariad(ARIA), Exelixis(EXEL)andOptimer(OPTR)
Biotech rally day with speculative news: ASCO,M&A,and Clinical News. Biotech stocks were green across the board with our mid-cap index of 33 stocks up 1%. ETF's were strong: FBT up 1.3%, IBB up 1.3% and XBI up 1.45%. The NAZ is up 1.11%. Some notable winners are: Ariad (ARIA $6.80) up 7.7%...
Nat Gas Is Being Re-Discovered:Price Up to $4.35-Update 3/24
Update after Inventory Report: Range $4.34-$4.48 Nat Gas prices up 10% in five sessions reached the highest level since Feb 4 as cold weather forecasts added to the bullish scenario. The EIA storage report showed a minor draw of 6 bcf which should continue with colder weather. Technicians see...
Biotech Winners Today Despite XOMA News
Good news boosted many biotech stocks today as the XOMA clinical trial failure of yet another diabetes drug did not scare away investors. Although the major ETF's were barely up, there were a lot of individual stock winners. Within the Rayno Life Science Portfolio there were winners:...
Rayno Snow Blog:Can There Ever Be Too Much Snow In The Sierras?
Got Snow? LaNina Delivers If anyone figures out what to do with excess snow you can make a bundle. For sure the West Coast will have plenty of water from the winter snow pack which was already above normal 2 weeks ago. Trucking it somewhere for festivals do not make sense with gasoline at $4+...
Biotech “Survivor”: Xoma (XOMA) Down 29% on Diabetes Drug Failure in Mid-Stage Study
But Cardiovascular Biomarker Indicates Anti-Inflammatory Activity For XOMA052 Xoma (XOMA $3.55) said its lead Type 2 diabetes drug-XOMA052- in a Phase 2b study failed to meet its main goal of lowering blood glucose levels. The trial failed to achieve its primary endpoint of reduction in...